Calcium acetate/magnesium carbonate: Difference between revisions
From WikiMD's Wellness Encyclopedia
CSV import Tags: Reverted mobile edit mobile web edit |
No edit summary Tag: Manual revert |
||
| Line 2: | Line 2: | ||
{{stb}} | {{stb}} | ||
{{No image}} | {{No image}} | ||
Latest revision as of 18:24, 18 March 2025
Calcium acetate/magnesium carbonate is a fixed-dose combination drug that contains 110 mg calcium and 60 mg magnesium ions and is indicated as a phosphate binder for dialysis patients suffering from hyperphosphataemia (abnormal high serum phosphorus levels). It is registered by Fresenius Medical Care under the trade names Renepho (Belgium) and OsvaRen (a number of other European countries)
| This article is a stub. You can help WikiMD by registering to expand it. |